IBDEI118 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16595,0)
 ;;=D57.1^^88^879^187
 ;;^UTILITY(U,$J,358.3,16595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16595,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,16595,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,16595,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,16596,0)
 ;;=D75.1^^88^879^185
 ;;^UTILITY(U,$J,358.3,16596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16596,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,16596,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,16596,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,16597,0)
 ;;=C90.30^^88^879^188
 ;;^UTILITY(U,$J,358.3,16597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16597,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,16597,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,16597,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,16598,0)
 ;;=D56.3^^88^879^189
 ;;^UTILITY(U,$J,358.3,16598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16598,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,16598,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,16598,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,16599,0)
 ;;=D56.9^^88^879^190
 ;;^UTILITY(U,$J,358.3,16599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16599,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,16599,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,16599,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,16600,0)
 ;;=M31.1^^88^879^192
 ;;^UTILITY(U,$J,358.3,16600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16600,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,16600,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,16600,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,16601,0)
 ;;=D51.2^^88^879^193
 ;;^UTILITY(U,$J,358.3,16601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16601,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,16601,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,16601,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,16602,0)
 ;;=D05.92^^88^879^36
 ;;^UTILITY(U,$J,358.3,16602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16602,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,16602,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,16602,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,16603,0)
 ;;=D05.91^^88^879^38
 ;;^UTILITY(U,$J,358.3,16603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16603,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,16603,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,16603,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,16604,0)
 ;;=D05.90^^88^879^34
 ;;^UTILITY(U,$J,358.3,16604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16604,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,16604,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,16604,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,16605,0)
 ;;=D51.0^^88^879^194
 ;;^UTILITY(U,$J,358.3,16605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16605,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,16605,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,16605,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,16606,0)
 ;;=D51.1^^88^879^195
 ;;^UTILITY(U,$J,358.3,16606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16606,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,16606,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,16606,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,16607,0)
 ;;=D51.9^^88^879^197
